The use of the name Mycobacterium w for the leprosy immunotherapeutic bacillus creates confusion with M. tuberculosis-W (Beijing strain): A suggestion

Infection, Genetics and Evolution

Volumn 8, Issue 1, 2008, Pages 100-101

  Talwar, Gursaran Pran ^a   Ahmed, Niyaz ^b   Saini, Vikram ^c  

^a Talwar Research Foundation   (India)

^b CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

^c UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOBACTERIUM ANTIGEN; RNA 16S;

ARTICLE; ATYPICAL MYCOBACTERIUM; BACILLUS; BACTERIAL STRAIN; IMMUNOTHERAPY; LEPROSY; MYCOBACTERIUM; MYCOBACTERIUM AURUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GENAVENSE; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM HAEMOPHILUM; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM MARINUM; MYCOBACTERIUM SCROFULACEUM; MYCOBACTERIUM SIMIAE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM SZULGAI; MYCOBACTERIUM TERRAE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM VACCAE; MYCOBACTERIUM W; MYCOBACTERIUM XENOPEI; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA SEQUENCE;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 36849002911     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2007.07.009     Document Type: Note

References (15)

1. Agerton T.B., Valway S.E., Blinkhorn R.J., Shilkret K.L., Reves R., Schluter W., et al. Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. Clin. Infect. Dis. 29 (1999) 85-92
2. Chaudhuri P., and Mukhopadhyay S. Bladder preserving approach for muscle invasive bladder cancer-role of Mycobacterium w. J. Indian Med. Assoc. 101 (2003) 559-560
3. Kharkar R. Immune recovery in HIV with Mycobacterium w. J. Indian Med. Assoc. 100 (2002) 578-579
4. Patel N., Deshpande M.M., and Shah M. Effect of an immunomodulator containing Mycobacterium w on sputum conversion in pulmonary tuberculosis. J. Indian Med. Assoc. 100 (2002) 191-193
5. Rath N., and Kar H.K. Efficacy of intradermal heat-killed Mycobacterium w in psoriasis: a pilot study. Int. J. Dermatol. 42 (2003) 756-757
6. Reddi P.P., Amin A.G., Khandekar P.S., and Talwar G.P. Molecular definition of unique species status of Mycobacterium w; a candidate leprosy vaccine strain. Int. J. Lepr. 62 (1994) 229-236
7. Saxena V.K., Singh U.S., and Singh A.K. Lepr. India 50 (1978) 588-596
8. Sharma P., Mukherjee R., Talwar G.P., Sarathchandra K.G., Singh P., et al. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years. Lepr. Rev. 76 (2005) 127-143
9. Singh I.G., Mukherjee R., and Talwar G.P. Resistance to intravenous inoculation of Mycobacterium tuberculosis H37 Rv in mice of different inbred strains following immunization with a leprosy vaccine based on Mycobacterium w. Vaccine. 9 (1991) 10-14
10. Talwar G.P. An immunotherapeutic vaccine for multibacillary leprosy. Int. Rev. Immunol. 18 (1999) 229-249
11. Talwar G.P., Zaheer S.A., Mukherjee R., Walia R., Suresh N.R., et al. Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patients. Vaccine 8 (1990) 121-129
12. Talwar, G.P., Mustafa, A.S., and other co-workers, 1978. 14 Papers in Golden Jubilee Issue Leprosy in India. 50, 492-597.
13. Zaheer S.A., Suresh N.R., Kar H.K., Sharma A.K., Mukherjee A., Mukherjee R., and Talwar G.P. Immunological upgrading with combined immunotherapy and chemotherapy in an LL patients: a case report. Lepr. Rev. 61 (1991) 297-302
14. Zaheer S.A., Mukherjee R., Ramkumar B., Misra R.S., Talwar G.P., et al. Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy. J. Infect. Dis. 167 (1993) 401-410
15. Zaheer S.A., Mukherjee A., Ramesh V., Beena K.R., Kar H.K., Sharma A.K., Mishra R.S., Kaur H., Walia R., and Talwar G.P. Immunotherapy benefits multibacillary patients with persistently high bacteriological index despite long term multidrug therapy. Immunol. Infect. Diseases 5 (1995) 115-122